-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Denali Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
- Denali Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $25.1M, a 5.53% decline year-over-year.
- Denali Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $106M, a 1.89% increase year-over-year.
- Denali Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $108M, a 8.27% increase from 2022.
- Denali Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $99.8M, a 17.1% increase from 2021.
- Denali Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $85.2M, a 69.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)